Rilmazafone

DB20558ExperimentalSmall molecule

Rilmazafone is a small molecule drug. The usage of the INN stem '-zafone' in the name indicates that Rilmazafone is a alozafone derivative. Rilmazafone has a monoisotopic molecular weight of...

Formula / weight: C₂₁H₂₀Cl₂N₆O₃ · 475.33 g/mol (avg)

Resolves to

Compound

UNIICU3H37T766CAS99593-25-6ChEMBLCHEMBL2107197ChEBI135767

Structure

InChIKeyKYHFRCPLIGODFH-UHFFFAOYSA-NSMILESCN(C)C(=O)C1=NN(C(CNC(=O)CN)=N1)C1=C(C=C(Cl)C=C1)C(=O)C1=C(Cl)C=CC=C1

Which companies are running trials of Rilmazafone, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account